David Halstead

• Corporate

Massachusetts

Since 2003

Massachusetts, 2003

U.S. Patent and Trademark Office, 1999

Associate

Ropes & Gray

Current

Current

David advises clients on patent portfolios in diverse technologies, including novel chemical and biological therapies, pharmaceutical formulations and drug delivery devices, chemical synthesis, analytical methods and instruments, nanotechnology, diagnostic agents and methods, carbohydrate chemistry and therapeutics, and polymers. In addition to ex parte patent prosecution, David handles adversarial matters in the U.S. Patent Trademark Office, including administrative appeals, interferences and recently introduced inter partes reexamination proceedings. David has substantial international IP law experience working with many foreign patent offices, and has assisted clients with opposition proceedings in both Europe and Australia.David helps clients devise effective patent strategies, manage product life-cycles, and navigate the existing patent landscape. David advises clients regarding Hatch-Waxman and Orange Book issues, conducts due diligence on intellectual property portfolios, identifies potential freedom-to-operate issues, and prepares opinions on freedom-to-operate and patent validity issues. In addition, David assists clients in protecting their commercial activities with trademarks and service marks.David also helps clients put their intellectual property to work. He drafts collaboration agreements, intellectual property licenses, material transfer agreements, non-disclosure agreements, and other documents that allow clients to create and manage relationships with partners, collaborators, investors, licensors, and licensees. He also has experience assisting clients in intellectual property enforcement, including identifying and communicating with potential infringers, litigating patents, and arbitrating disputes.Before beginning his legal career, David obtained his Ph.D. in organic chemistry from Harvard University, where he studied the synthesis of organic molecules and completed the total synthesis of discodermolide in the laboratory of Professor David A. Evans. Drawing on the strong scientific foundation he obtained at Harvard, David has counseled clients in a wide variety of fields, including drug development, biotechnology, pharmaceutical formulation, drug delivery, chemical methodology, polymer science, medical devices, nanotechnology, and materials science.

Harvard Law School

J.D.

2002

Harvard University

Ph.D.

1999

Organic Chemistry

The Pennsylvania State University

B.S.

1993

Chemistry, summa cum laude